|
|
|
|
||
SlingYOUR response is what I would expect from someone trying to be helpful on this board. Splay's response was intended to needle and mock. I really don't care about the statistics. We all know getting a drug to market is extremely expensive and uncertain, riddled with disappointments and failures...and even if it does make it through, its market performance is almost always doubtful. It is the manner of presentation of those facts on this board that I am highlighting. |
return to message board, top of board |